NCT00057850View on ClinicalTrials.gov

BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

July 31, 2003

Conditions
Head and Neck Cancer
Interventions
DRUG

cisplatin

DRUG

ixabepilone

Trial Locations (1)

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00057850 - BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | Biotech Hunter | Biotech Hunter